Eberhard Naja, Balmer Vreni, Müller Joachim, Müller Norbert, Winter Rolf, Pou Soviti, Nilsen Aaron, Riscoe Mike, Francisco Samuel, Leitao Alexandre, Doggett J Stone, Hemphill Andrew
Vetsuisse Faculty, Institute of Parasitology, University of Bern, Bern, Switzerland.
VA Portland Health Care System Research and Development Service, Portland, OR, United States.
Front Vet Sci. 2020 Feb 26;7:96. doi: 10.3389/fvets.2020.00096. eCollection 2020.
Endochin-like quinolones (ELQs) potently inhibit the proliferation of , and by targeting the cytochrome Qo and Qi sites and interfering with oxidative phosphorylation and pyrimidine biosynthesis. The activities of 14 different ELQs were assessed against tachyzoites grown in human foreskin fibroblasts (HFF) by quantitative real time PCR. The values for 50% proliferation inhibition (IC50) of five ELQs were determined in a 3-days growth assay after an initial screen of 12 ELQs at 0.01, 0.1, and 1 μM. The IC50s of ELQ-121, -136, and -316 were 0.49, 2.36, and 7.97 nM, respectively. The IC50s of ELQs tested against were higher than IC50s previously observed for and . However, the cytochrome sequence and the predicted Qo and Qi ELQ binding sites in the , and cytochrome are virtually identical, suggesting that the differences in ELQ susceptibility are not due to variations in the substrate binding sites. TEM of ELQ-treated parasites primarily demonstrated alterations within the parasite mitochondrion, profound thickening of the nuclear membrane, as well as increased vacuolization within the tachyzoite cytoplasm. Long-term treatment assays of intracellular with ELQs for up to 20 days followed by the release of drug pressure caused a substantial delay in parasite growth and proliferation while ELQs were present, but parasite proliferation resumed days after ELQs were removed. Interestingly, structural alterations persisted after ELQ removal and parasite proliferation was slowed. These findings provide a basis for further studies of ELQs as therapeutic options against infection.
类内二喹啉(ELQs)通过靶向细胞色素bc1复合物的Qo和Qi位点并干扰氧化磷酸化和嘧啶生物合成,有效抑制疟原虫、弓形虫和巴贝斯虫的增殖。通过定量实时PCR评估了14种不同ELQs对在人包皮成纤维细胞(HFF)中生长的弓形虫速殖子的活性。在对12种ELQs进行0.01、0.1和1μM的初步筛选后,通过3天生长试验确定了5种ELQs的50%增殖抑制(IC50)值。ELQ-121、-136和-316的IC50分别为0.49、2.36和7.97 nM。针对巴贝斯虫测试的ELQs的IC50高于先前观察到的针对疟原虫和弓形虫的IC50。然而,疟原虫、弓形虫和巴贝斯虫的细胞色素bc1序列以及预测的Qo和Qi ELQ结合位点几乎相同,这表明ELQ敏感性的差异不是由于底物结合位点的变化。ELQ处理的寄生虫的透射电子显微镜观察主要显示寄生虫线粒体内的改变、核膜的显著增厚以及速殖子细胞质内空泡化增加。用ELQs对细胞内弓形虫进行长达20天的长期处理试验,随后解除药物压力,在ELQs存在时导致寄生虫生长和增殖显著延迟,但在ELQs去除几天后寄生虫增殖恢复。有趣的是,ELQ去除后结构改变仍然存在,并且寄生虫增殖减慢。这些发现为进一步研究ELQs作为抗弓形虫感染的治疗选择提供了基础。